Valuation: Supergenics

Market Cap 29.11M 7.11M 6.23M 5.76M 5.3M 10M 686M 10.16M 68.9M 27.01M 336M 26.71M 26.12M 1.16B P/E 2024
-9.45x
P/E 2025 -8.61x
Enterprise Value 32.5M 7.94M 6.96M 6.43M 5.92M 11.17M 766M 11.34M 76.94M 30.16M 375M 29.82M 29.17M 1.29B EV / Sales 2024
13.9x
EV / Sales 2025 5.78x
Free-Float
41.6%
Yield 2024 *
-
Yield 2025 -
1 year 0.2
Extreme 0.205
0.25
3 years 0.15
Extreme 0.15
0.6
5 years 0.15
Extreme 0.15
0.6
10 years 0.15
Extreme 0.15
0.6
Manager TitleAgeSince
Chief Executive Officer 48 24/04/2019
Corporate Secretary - 02/06/2022
Director TitleAgeSince
Director/Board Member 60 24/04/2019
Director/Board Member 48 24/04/2019
Director/Board Member 46 28/01/2022
Change 5-day change 1-year change 3-year change Capi.($)
+21.95%-.--%-16.67%+13.64% 7.11M
-0.83%-3.88%-0.32%+14.04% 48.71B
-3.10%-1.94%+370.99%+572.60% 38.35B
-0.46%+2.18%+5.44%+61.01% 34.53B
-1.14%-1.76%+26.94%-9.93% 34.03B
-1.82%-1.43%+0.52%+31.85% 26.77B
-3.54%-5.08% - - 15.64B
-1.82%-0.43%+69.28%+113.82% 15.08B
-1.72%+1.28%+13.48%+14.37% 14.18B
-2.25%+0.05%+15.77%-32.83% 12.73B
Average +0.53%-1.01%+53.94%+86.51% 24B
Weighted average by Cap. -1.66%-1.44%+74.73%+119.29%

Financials

2024 2025
Net sales 5.32M 1.3M 1.14M 1.05M 969K 1.83M 125M 1.86M 12.6M 4.94M 61.35M 4.88M 4.78M 211M 5.63M 1.37M 1.2M 1.11M 1.02M 1.93M 133M 1.96M 13.32M 5.22M 64.85M 5.16M 5.05M 223M
Net income -7.28M -1.78M -1.56M -1.44M -1.33M -2.5M -172M -2.54M -17.23M -6.76M -83.94M -6.68M -6.53M -289M -3.37M -822K -721K -666K -613K -1.16M -79.3M -1.17M -7.97M -3.12M -38.8M -3.09M -3.02M -134M
Net Debt 4.48M 1.09M 959K 886K 815K 1.54M 105M 1.56M 10.6M 4.15M 51.61M 4.11M 4.02M 178M 3.39M 829K 727K 672K 618K 1.17M 79.97M 1.18M 8.03M 3.15M 39.13M 3.11M 3.05M 135M
Logo Supergenics
Supergenics Berhad is a Malaysia-based management and investment holding company. The Company operates through three segments: Integrated Turnkey Solutions, Biomedical, and Investment Holding. Its Integrated Turnkey Solutions segment is engaged in the provision of integrated turnkey solutions for the related development of cleanrooms and the provision of related maintenance services. Its Biomedical segment is engaged in the provision of administrative health care services, operating medical laboratories, and developing regenerative wellness products. The Company provides laboratory services, including storage and handling of stem cell samples. Its services include stem cells, mesenchymal stem cells (MSC), natural killer (NK) cells, exosomes, and MSC exosomes. Its subsidiaries include Supergenics Solution Sdn. Bhd., Supergenics Life Science Sdn. Bhd., Supergenics Therapeutic Sdn. Bhd., Supergenics Bio Agro Sdn. Bhd., Supergenics Stembank Sdn. Bhd., and Supergenics Global Sdn. Bhd.
Employees
-
  1. Stock Market
  2. Stocks
  3. 03033 Stock